Listen to Dr. Leanne Ward, a leading doctor in pediatric bone disorders, share the early signs and symptoms that can help identify and diagnose XLH. Full story: TheBalancingAct.com/rare. Learn more: xlhlink.comand @KyowaKirin_US

KKNA offices in the U.S. and Canada will be closed July 1st through 5th to allow our teams to rest and recharge. We wish you and yours a Happy Independence Day!

Many general practitioners may not recognize #XLH symptoms, leading to delayed diagnosis. An XLH specialist who is familiar with the disease can provide personalized care and support. #LookDeeper

🤝40 years of collaboration - one shared vision of improving #patient lives. Amgen 🧪🔬🧬 hosted KyowaKirin this week to celebrate four decades of #partnership to create innovative therapies across multiple disease areas.

Denise and Bernard Coley are helping to bridge healthcare gaps in Parkinson’s Disease for Black and under-engaged communities. Learn about their work here: bit.ly/3SH9D7P #ParkinsonsAwareness #HealthEquity #PatientAdvocacy

We are proud to join North Carolina’s innovative and growing #biopharmaceutical community.

September is #BloodCancerAwarenessMonth, which serves as an opportunity for us at @KyowaKirinIncUS to reflect on and recommit to the work we do with the Cutaneous T-Cell Lymphoma (#CTCL) patient community.

The countdown is on to the groundbreaking ceremony for our new state-of-the-art global #manufacturing campus in Sanford, NC! Our President, Steve Schaefer, shares his thoughts on this milestone in the company’s history and what it means for #patients and the Sanford community.

Approximately 40% of people living with #atopicdermatitis consider their condition to be moderate-to-severe. This is more than just a number for Amgen 🧪🔬🧬 and @KyowaKirin_US, that's why we're committed to addressing unmet needs faced by the atopic dermatitis community.

Two subtypes of cutaneous T-cell lymphoma (#CTCL) - Mycosis Fungoides and Sézary Syndrome - manifest and spread in different ways, including within the blood. Learn more at bit.ly/3ZjHk3o #BloodCancerAwarenessMonth

Today marks a huge step forward in our plan to expand global production capacity and bring life-changing medicines to #patients. Our new #manufacturing site in Sanford, NC will create 100+ jobs across a range of functions. Stay tuned for groundbreaking ceremony highlights!

Check out the latest findings from the XLH Disease Monitoring Program (DMP) published in JBMRPlus. Join us at ASBMR’s Annual Meeting in Toronto, September 27-30, 2024 for additional insights. Learn more here: bit.ly/3XCQQO8 #raredisease #asbmr

The power of #omnichannel communication will be the focus of a discussion led by our own Jay McMeekan, Executive Director, Omnichannel Customer Experience, who is leading KKNA’s digital evolution. Tune in hear the latest at Fierce’s Fierce Digital Pharma East event. #DPEAST

Approximately 40% of people living with #atopicdermatitis consider their condition to be moderate-to-severe. This is more than just a number for Amgen 🧪🔬🧬 and @KyowaKirin_US, that's why we're committed to addressing unmet needs faced by the atopic dermatitis community.

Our own Mitchell Katz, Ph.D. SVP, Global Clinical Operations, is facilitating a panel with #pharma industry leaders on opportunities for engaging patients, patient groups, and experts in the #raredisease community at #DPHARM2024. Join the discussion at 1:20 pm ET on Sept. 18.

Kyowa Kirin is proud to recognize World Lymphoma Awareness Day💚 Around the world, our employees are dedicated to raising awareness and addressing the needs of #CTCL patients and their care communities. #WLAD2024 #BloodCancerAwarenessMonth

Support is essential when living with cutaneous T-cell lymphoma. #CTCL patients Susan and Ron talk about the importance of having someone by your side through the ups and downs of living with rare blood cancer. bit.ly/47qkVDP #WLAD2024 #HonestTalk #BCAM

We’re excited that Masayuki Kai, Vice President and Head of KKNA Research, is speaking at UC San Diego’s inaugural Gene Therapy Initiative Symposium where researchers and industry experts will share the latest scientific findings in #cellandgenetherapy. #GTI #research

Thanks to her tenacity and self-advocacy, Linda was able to receive her cutaneous T-cell lymphoma (#CTCL) #diagnosis 3 years after first recognizing symptoms. This #BloodCancerAwarenessMonth, we’re honored to share her journey. WATCH “Uncharted": bit.ly/3MKYyPI

Kyowa Kirin’s Global Head of HEOR, Angela Williams, PhD, is thrilled to announce the acceptance of 10 abstracts at #ASBMR2024 and shares why these data are critical to advance understanding and management of #XLH for #patients and clinicians. Learn more: bit.ly/3XMmLf2